Lenz & Staehelin advised Prof. Dr. Martin Janssen in connection with the sale of Ecofin Investment Consulting – a company founded by Janssen himslef – to the Vaudoise Group. The company Headquartered in Zurich, Ecofin Investment Consulting
As of October 1st 2025, Christine Hohl (pictured) is joining Wenger Plattner as head of the firm’s financing practice, after her tenure at Loyens & Loeff. Hohl’s work mainly concentrates on international and national
Walder Wyss advised Bobst Group throughout the issuance of CHF 200m senior unsecured bonds maturing in 2030 and with 2.05% coupon. The bonds in question are set to debut on the SIX Swiss Exchange. UBS, BNP Paribas,
Altenburger advised Ensemble Hospitalier de la Côte (EHC) – a healthcare network encompassing 36 medical centers throughout Switzerland – on its acquisition of Niedol Center, a Renens-based specialist in dialysis. The Altenburger team Partner Manuel Moor (corporate/
Homburger advised Landis+Gyr on the divestment of its EMEA business to private equity investor Aurelius, for an enterprise value of USD 215 m. The divestment encompasses five production sites across EMEA and involves a workforce
Wenger Plattner advised TVH Consulting – a provider for the integration of Microsoft, SAP ERP and BI solutions – on its acquisition of Augusta Reeves, a specialist in the distribution and integration of SAP. The Wenger Plattner
Walder Wyss advised Groupe E on a CHF 250m bond issuance. The transaction encompasses a CHF 100m 4-year tranche with a fixed coupon of 0.750% and a CHF 150m 10-year tranche with a fixed coupon
Niederer Kraft Frey (NKF) advised SpineArt, as the Swiss medtech specialist raised CHF 25 million in a capital increase backed by investors Gimv and EGS Beteiligungen (EGSB). In connection with the operation, Bär & Karrer
Niederer Kraft Frey (NKF) advised private equity firm EOS Partners on the acquisition of a majority stake in Flexicode and Flexicode Schweiz. The parties Headquartered in Munich, EOS Partners manages EUR 500 million in AUM, focusing
Baker McKenzie advised Swiss medical regeneration technologies specialist Geistlich Pharma (Geistlich) on its acquisition of a minority stake in TRI Dental Implants (TRI), a provider of digital implant solutions which developed an abutment-free dental implant
